• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Transmembrane protein 33 (TMEM33), Truncated

ACP06882

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP06882 Target NameTMEM33
Target SynonymsTMEM33; DB83; Transmembrane protein 33; Protein DB83; SHINC-3FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP57088
Background Information
  • Uniprot Id

    P57088

  • Target Species

    Human

  • Target Name

    TMEM33

  • Target Full Name

    Transmembrane protein 33

  • Target Function

    Acts as a regulator of the tubular endoplasmic reticulum (ER) network. Suppresses the RTN3/4-induced formation of the ER tubules. Positively regulates PERK-mediated and IRE1-mediated unfolded protein response signaling.

  • Target Subcellular Location

    Endoplasmic reticulum membrane; Multi-pass membrane protein. Melanosome. Nucleus envelope.

  • Target Protein Families

    PER33/POM33 family

  • Target Tissue Specificity

    Prostate cancer and several cancer cell lines (at protein level). Widely expressed. Expressed at higher levels in endocrine-resistant breast cancer cells as compared to endocrine-sensitive breast cancer cells. Expressed at higher levels in early recurrenc

  • Target Synonyms

    TMEM33; DB83; Transmembrane protein 33; Protein DB83; SHINC-3

Inquire Recombinant Human Transmembrane protein 33 (TMEM33), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification